The risk of acute hepatitis B among adults with diabetes mellitus is unknown. We investigated the association between diagnosed diabetes and acute hepatitis B.
Methods:
Confirmed acute hepatitis B cases were reported in 2009–2010 to eight Emerging Infections Program (EIP) sites; diagnosed diabetes status was determined. Behavioral Risk Factor Surveillance System respondents residing in EIP sites comprised the comparison group. Odds ratios (ORs) comparing acute hepatitis B among adults with diagnosed diabetes versus without diagnosed diabetes were determined by multivariate logistic regression, adjusting for age, sex, and race/ethnicity, and stratified by the presence or absence of risk behaviors for hepatitis B virus (HBV) infection.
Results:
During 2009–2010, EIP sites reported 865 eligible acute hepatitis B cases among persons aged ≥23 years; 95 (11.0%) had diagnosed diabetes. Comparison group diabetes prevalence was 9.1%. Among adults without hepatitis B risk behaviors and with reported diabetes status, the OR for acute hepatitis B comparing adults with and without diabetes was 1.9 (95% confidence interval [CI] = 1.4, 2.6); ORs for adults ages 23–59 and ≥60 years were 2.1 (95% CI = 1.6, 2.8) and 1.5 (95% = CI 0.9, 2.5), respectively.
Conclusions:
Diabetes was independently associated with an increased risk for acute hepatitis B among adults without HBV risk behaviors.
Centers for Disease Control and Prevention (CDC). National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
2.
BoyleJPThompsonTJGreggEWBarkerLEWilliamsonDF. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr.2010;8: 29.
3.
American Diabetes Association. Standards of medical care in diabetes–2011. Diabetes Care.2011;34Suppl 1: S11–61
4.
Centers for Disease Control and Prevention. Diabetes data and trends. www.cdc.gov/diabetes/statistics. Accessed November 8, 2011.
5.
BurrowsNR. Update: National diabetes statistics. Presented at: Meeting of the Advisory Committee on Immunization Practices (ACIP), Atlanta, GA, February 24, 2011. http://www.cdc.gov/vaccines/recs/acip/.
6.
KlonoffDC. Improving the safety of blood glucose monitoring. J Diabetes Sci Technol.2011;5 (6): 1307–11.
7.
LouieRFLauMJLeeJHTangZKostGJ. Multicenter study of the prevalence of blood contamination on point-of-care glucose meters and recommendations for controlling contamination. Point Care.2005;4 (4): 158–63.
8.
ThompsonNDBarryVAlelisKCuiDPerzJF. Evaluation of the potential for bloodborne pathogen transmission associated with diabetes care practices in nursing homes and assisted living facilities, Pinellas County. J Am Geriatr Soc.2010;58 (5): 914–8.
9.
SchaeferMKJhungMDahlMSchillieSSimpsonCLlataELink-GellesRSinkowitz-CochranRPatelPBolyardESehulsterLSrinivasanAPerzJF. Infection control assessment of ambulatory surgical centers. JAMA.2010;303 (22): 2273–9.
10.
WiseMEMarquezPSharapovUHathawaySKatzKTolanSBeatonADrobeniucJKhudyakovYHuDJPerzJThompsonNDBancroftE. Outbreak of acute hepatitis B virus infections associated with podiatric care at a psychiatric long-term care facility. Am J Infect Control.2012;40 (1): 16–21.
11.
BondWWFaveroMSPetersenNJGravelleCREbertJWMaynardJE. Survival of hepatitis B virus after drying and storage for one week. Lancet.1981;1 (8219): 550–1.
12.
FaveroMSBondWWPetersenNJBerquistKRMaynardJE. Detection methods for study of the stability of hepatitis B antigen on surfaces. J Infect Dis.1974;129 (2): 210–2.
13.
MastEEWeinbaumCMFioreAEAlterMJBellBPFinelliLRodewaldLEDouglasJMJrJanssenRSWardJW; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults. MMWR Recomm Rep.2006;55 (RR-16): 1–33.
HyamsKC. Risks of chronicity following acute hepatitis B virus infection: A review. Clin Infect Dis.1995;20 (4): 992–1000.
16.
WeinbaumCMWilliamsIMastEEWangSAFinelliLWasleyANeitzelSMWardJW; Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep.2008;57 (RR-8): 1–20.
17.
ThompsonNDSchaeferMK. “Never events”: Hepatitis B outbreaks and patient notifications resulting from unsafe practices during assisted monitoring of blood glucose, 2009–2010. J Diabetes Sci Technol.2011;5 (6): 1396–402.
18.
Centers for Disease Control and Prevention (CDC). Notes from the field: Deaths from acute hepatitis B virus infection associated with assisted blood glucose monitoring in an assisted-living facility-North Carolina, August-October 2010. MMWR Morb Mortal Wkly Rep.2011;60 (6): 182.
19.
CounardCAPerzJFLinchangcoPCChristiansenDGanova-RaevaLXiaGJonesSVernonMO. Acute hepatitis B outbreaks related to fingerstick blood glucose monitoring in two assisted living facilities. J Am Geriatr Soc.2010;58 (2): 306–11.
20.
ThompsonNDPerzJF. Eliminating the blood: Ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies. J Diabetes Sci Tehnol.2009;3 (2): 283–8.
21.
Centers for Disease Control and Prevention (CDC). Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term-care facilities—Mississippi, North Carolina, and Los Angeles County, California, 2003–2004. MMWR Morb Mortal Wkly Rep.2005;54 (9): 220–3.
22.
SchaffzinJKSouthwickKLClementEJKoningsFGanova-RaevaLXiaGKhudyakovYJohnsonGS. Transmission of hepatitis B virus associated with assisted monitoring of blood glucose at an assisted living facility in New York State. Am J Infect Control.2012. Epub ahead of print.
Immunization Action Coalition. Hepatitis B prevention mandates for daycare and K-12. www.immunize.org/laws/hepb.asp. Accessed November 7, 2011.
27.
ZhangXDeckerFHLuoHGeissLSPearsonWSSaaddineJBGreggEWAlbrightA. Trends in the prevalence and comorbidities of diabetes mellitus in nursing home residents in the United States: 1995–2004. J Am Geriatr Soc.2010;58 (4): 724–30.
28.
AverhoffFMahoneyFColemanPSchatzGHurwitzEMargolisH. Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med.1998;15 (1): 1–8.
29.
WasleyAKruszon-MoranDKuhnertWSimardEPFinelliLMcQuillanGBellB. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis.2010;202 (2): 192–201.
30.
SchillieSFXingJMurphyTVHuDJ. Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999–2010. J Viral Hepat.2012. Epub ahead of print.
31.
GulcanAGulcanETokerABulutIAkcanY. Evaluation of risk factors and seroprevalence of hepatitis B and C in diabetic patients in Kutahya, Turkey. J Investig Med.2008;56 (6): 858–63.
32.
HalotaWMuszynskaMPawlowskaM. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes. Med Sci Monit.2002;8 (7): CR516–9.
33.
SangiorgioLAttardoTGangemiRRubinoCBaroneMLunettaM. Increased frequency of HCV and hepatitis B infection in type 2 diabetic patients. Diabetes Res Clin Pract.2000;48 (2): 147–51.
34.
SavagnoneECarusoVMondelloPPattiSSpicolaLSpanoC. Hepatitis B virus in diabetic patients. Acta Diabetol Lat.1980;17 (3–4): 207–11.
35.
Centers for Disease Control and Prevention. Outbreaks related to healthcare: Healthcare-associated hepatitis B and C outbreaks reported to CDC in 2008–2011. www.cdc.gov/hepatitis/outbreaks. Accessed March 29, 2012.
36.
Centers for Disease Control and Prevention. Guide to infection prevention for outpatient settings: Minimum expectations for safe care. www.cdc.gov/HAI/prevent/prevention.html. Accessed December 12, 2011.
37.
PerzJFGrytdalSBeckSFireteanuAMPoissantTRizzoEBornschlegelKThomasABalterSMillerJKlevensMFinelliL. Case-control study of hepatitis B and hepatitis C in older adults: Do healthcare exposures contribute to burden of new infections? Hepatology. 2012. Epub ahead of print.
38.
KondoYTsukadaKTakeuchiTMitsuiTIwanoKMasukoKItohTTokitaHOkamotoHTsudaF. High carrier rate after hepatitis B virus infection in the elderly. Hepatology.1993;18 (4): 768–74.
39.
MastEEMargolisHSFioreAEBrinkEWGoldsteinSTWangSAMoyerLABellBPAlterMJ; Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: Immunization of infants, children, and adolescents. MMWR Recomm Rep.2005;54 (RR-16): 1–31.
40.
Centers for Disease Control and Prevention (CDC). Use of hepatitis B vaccination for adults with diabetes mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep.2011;60 (50): 1709–11.
41.
Institute of Medicine. Adverse effects of vaccines: Evidence and causality. Washington DC: The National Academies Press; 2012.
42.
DouvinCSimonDCharlesMADeforgesLBierlingPLehnerVBudkowskaADhumeauxD. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen. Diabetes Care.1997;20 (2): 148–51.
43.
BouterKPDieperslootRJWismansPJMeylingFH GmeligHoekstraJBHeijtinkRAvan HattumJ. Humoral immune response to a yeast-derived hepatitis B vaccine in patients with type 1 diabetes mellitus. Diabet Med.1992;9 (1): 66–9.
